December 8, 2025JAC-Antimicrobial ResistanceOpen Access

P27 Carbapenem-resistant Acinetobacter baumannii : a challenge in the intensive care units

View Full Paper

Ask AI

Bookmark

Authors

RBRrezarta BajramiUniversity Clinical Center of Kosovo ADAida DuriqiUniversity Clinical Center of Kosovo

Discussion

Member takes

Implication

Epidemiological study found high mortality rates due to healthcare-associated infections from Acinetobacter baumannii, highlighting urgent infection control needs.

Key Points

Colistin demonstrated sensitivity in 97.85% of Acinetobacter baumannii isolates, making it crucial for treatment.
A significant majority of isolates exhibited resistance to carbapenems, with 96.65% classified as multidrug-resistant.
A laboratory-based evaluation study was conducted in 2024, focusing on antimicrobial susceptibility testing and resistance genes.
Ongoing surveillance of Acinetobacter baumannii is essential to manage infections and improve patient outcomes in intensive care settings.

Cite This Study

Bajrami et al. (2025) studied this question.

synapsesocial.com/papers/693624984fa91c937236c017 https://doi.org/10.1093/jacamr/dlaf230.034

View Full Paper

Ask AI

Bookmark

Implication

Epidemiological study found high mortality rates due to healthcare-associated infections from Acinetobacter baumannii, highlighting urgent infection control needs.

P27 Carbapenem-resistant Acinetobacter baumannii : a challenge in the intensive care units

Discussion

Member takes

Implication

Key Points

Cite This Study

P27 Carbapenem-resistant Acinetobacter baumannii : a challenge in the intensive care units

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider